Ebola Survivor - Dr. Ian Crozier
Dr. Ian Crozier contracted Ebola in Sierra Leone while treating Ebola patients in the government hospital in Kenema as a volunteer for the World health Organization. He was evacuated to Emory University Hospital in Atlanta, Georgia on Sept. 9, 2014, the third American with Ebola to be airlifted there from West Africa. He spent an agonizing 40 days in the hospital before finally recovering. Less than two months later, he developed soaring pressure in his left eye, with nausea and headaches. Test results were completely unexpected: the inside of his left eye was teeming with Ebola. Dr. Crozier, who also suffers from hearing loss, joint and muscle pain, disabling fatigue, problems with memory loss and word-finding, calls himself a poster child for “post-Ebola syndrome”. He describes his experience in great detail in this lengthy interview, which is segmented by questions on the screen. The interview was conducted by the US Army Medical Research Institute of Infectious Diseases (USAMRIID) at the FDA TV Studio in Maryland in May 2015.
Видео Ebola Survivor - Dr. Ian Crozier канала U.S. Food and Drug Administration
Видео Ebola Survivor - Dr. Ian Crozier канала U.S. Food and Drug Administration
Показать
Комментарии отсутствуют
Информация о видео
15 сентября 2015 г. 0:54:42
01:35:09
Другие видео канала
Ebola Outbreak in Uganda: Part 2 Ebola Case StudyNatural History Studies for Rare DiseasesEbola Outbreak in Uganda: Part 1 BackgroundPublic Meeting on Patient Focused Drug Development for Alpha 1 Antitrypsin Part 2Public Meeting: Patient-Focused Drug Development for Systemic SclerosisVaccines and Related Biological Products Advisory Committee – 9/17/2021Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) Meeting - Day 1FDA Guidance on Manufacturing During COVID-19 and High AbsenteeismPromotional Submissions in eCTD Format - Grouped SubmissionsRisk Management and Application Approaches in Responding to Supply Chain Constraints During PHECellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) Meeting - Day 2Conversations on Cancer: The Future of Childhood Cancer Drug Development: Is the Sky the Limit?Original TYPE V VMF Section 9.0 Depyrogenation Walk ThroughOriginal TYPE V VMF Section 6.0 Sterilization of Components Equipment by Irradiation Walk Through25th Annual FDA Commissioned Corps Promotion CeremonyOSBA WebinarInspections and Use of Alternate Tools During the COVID-19 Public Health Emergency + Q/A PanelOriginal TYPE V VMF Section 14.0 Evidence of Formal Written Procedures Walk ThroughOriginal TYPE V VMF Section 11.0 Media Fills Walk ThroughOriginal TYPE V VMF Section 13.0 Other Information Walk Through